Cargando…

HGG-36. HIF-2: A NEW DRUG TARGET IN PEDIATRIC HIGH-GRADE GLIOMA WITH PROMISING PRECLINICAL RESULTS

Pediatric high-grade gliomas (pHGGs) have a very dismal prognosis and need new innovative strategy for treatment. Despite the past discovery of histone H3 driver mutations, we are not able for instance to stop this induced epigenetic remodulation. Therefore, proactive translational studies wish to g...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Quentin, Pierrevelcin, Marina, Papin, Christophe, Dontenwill, Monique, Entz-Werlé, Natacha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715113/
http://dx.doi.org/10.1093/neuonc/noaa222.317

Ejemplares similares